![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 17, 2022 4:23:05 PM
The Aug 16th PR indicates we are now in the 'shortly thereafter' timeframe. unfortunately terms like 'shortly' are relative. Could happen within a few days or shortly can be thought of as several weeks.
When the data access plan was submitted to the FDA for unblinding the 210, it (only) took them 18 calendar days to OK it. If they (FDA) have an idea what the new primary end point may look like it could be a similar timeframe once the new end points are submitted. I'm thinking the timeframe for approval of the amended Study protocol will put us around mid September. Hopefully the DSMB is looking at the updated end points and can have a recommendation ready as to whether to halt and unblind the overall study once the FDA approves. Maybe it will occur around the time that the u-Haul is loaded - say around Sept 19?
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM